U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
Forigerimod (also known as IPP-201101) a phosphopeptide is being investigated for the treatment of Lupus Erythematosus, Systemic. This drug is completed phase III clinical trials and is ready for licensing.

Approval Year

PubMed

PubMed

TitleDatePubMed

Sample Use Guides

200 mcg of IPP-201101 (FORIGERIMOD) will be administered subcutaneously every 4 weeks for 24 weeks.
Route of Administration: Other
Substance Class Protein
Created
by admin
on Sat Dec 16 03:58:14 UTC 2023
Edited
by admin
on Sat Dec 16 03:58:14 UTC 2023
Protein Sub Type
Sequence Type COMPLETE
Record UNII
1JRB6UKG4Q
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FORIGERIMOD
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
forigerimod [INN]
Common Name English
RIGERIMOD
Common Name English
L-TYROSINE, L-ARGINYL-L-ISOLEUCYL-L-HISTIDYL-L-METHIONYL-L-VALYL-L-TYROSYL-L-SERYL-L-LYSYL-L-ARGINYL-O-PHOSPHONO-L-SERYLGLYCYL-L-LYSYL-L-PROLYL-L-ARGINYLGLYCYL-L-TYROSYL-L-ALANYL-L-PHENYLALANYL-L-ISOLEUCYL-L-.ALPHA.-GLUTAMYL-
Common Name English
FORIGERIMOD [USAN]
Common Name English
Forigerimod [WHO-DD]
Common Name English
IPP-201101
Code English
IPP201101
Code English
Code System Code Type Description
FDA UNII
1JRB6UKG4Q
Created by admin on Sat Dec 16 03:58:14 UTC 2023 , Edited by admin on Sat Dec 16 03:58:14 UTC 2023
PRIMARY
ChEMBL
CHEMBL2103866
Created by admin on Sat Dec 16 03:58:14 UTC 2023 , Edited by admin on Sat Dec 16 03:58:14 UTC 2023
PRIMARY
USAN
XX-41
Created by admin on Sat Dec 16 03:58:14 UTC 2023 , Edited by admin on Sat Dec 16 03:58:14 UTC 2023
PRIMARY
INN
9405
Created by admin on Sat Dec 16 03:58:14 UTC 2023 , Edited by admin on Sat Dec 16 03:58:14 UTC 2023
PRIMARY
NCI_THESAURUS
C166505
Created by admin on Sat Dec 16 03:58:14 UTC 2023 , Edited by admin on Sat Dec 16 03:58:14 UTC 2023
PRIMARY
CAS
497156-60-2
Created by admin on Sat Dec 16 03:58:14 UTC 2023 , Edited by admin on Sat Dec 16 03:58:14 UTC 2023
PRIMARY
DRUG BANK
DB12490
Created by admin on Sat Dec 16 03:58:14 UTC 2023 , Edited by admin on Sat Dec 16 03:58:14 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
INGREDIENT -> STARTING MATERIAL
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL